SIENNA BIOPHARMACEUTICALS IN's ticker is SNNAQ and the CUSIP is 82622H108. A total of 49 filers reported holding SIENNA BIOPHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $547,000 | +3.4% | 235,967 | +3.6% | 0.00% | – |
| Q4 2018 | $529,000 | -84.6% | 227,818 | -1.9% | 0.00% | – |
| Q3 2018 | $3,441,000 | +3.6% | 232,226 | +6.2% | 0.00% | – |
| Q2 2018 | $3,322,000 | -14.6% | 218,598 | +5.6% | 0.00% | – |
| Q1 2018 | $3,888,000 | +362.9% | 207,026 | +347.5% | 0.00% | – |
| Q4 2017 | $840,000 | +43.3% | 46,259 | +75.8% | 0.00% | – |
| Q3 2017 | $586,000 | – | 26,307 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 758,610 | $1,760,000 | 1.30% |
| Wildcat Capital Management, LLC | 295,613 | $686,000 | 0.45% |
| PFM Health Sciences, LP | 1,576,619 | $3,658,000 | 0.10% |
| Cohen Capital Management, Inc. | 108,010 | $251,000 | 0.07% |
| Partner Investment Management, L.P. | 15,283 | $35,000 | 0.04% |
| CLOUGH CAPITAL PARTNERS L P | 136,228 | $316,000 | 0.04% |
| Tower Research Capital LLC (TRC) | 12,183 | $29,000 | 0.00% |
| Assenagon Asset Management S.A. | 69,931 | $162,000 | 0.00% |
| Ballentine Partners, LLC | 16,700 | $39,000 | 0.00% |
| A.R.T. Advisors, LLC | 10,206 | $24,000 | 0.00% |